Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES via SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES
2026 · third_quarter · Q3
Issues related to pharmaceutical supply chain resilience and expansion of domestic manufacturing capacity for active pharmaceutical ingredients, key starting materials, and critical chemical inputs. Issues related to federal policies intended to reduce U.S. reliance on foreign sources for essential medicines and pharmaceutical inputs, including the ASPR 86 essential medicines initiative. Issues related to regulatory and federal policy barriers affecting investment in domestic pharmaceutical and specialty chemical manufacturing.
Issues related to the Federal Aviation Administration's proposed rule governing unmanned aircraft systems (UAS) operations over certain fixed-site facilities, including chemical manufacturing facilities; facility eligibility criteria; protection of confidential facility information; implementation timelines; and coordination with the Department of Homeland Security and Cybersecurity and Infrastructure Security Agency.
Source: Senate LDA
Issues related to reshoring and expansion of domestic specialty chemical manufacturing capacity. Issues related to federal policies supporting domestic production of pharmaceutical ingredients, key starting materials, and other critical chemical inputs. Issues related to regulatory policies affecting investment in and competitiveness of U.S. chemical manufacturing.
Issues related to tariffs, international trade, and the competitiveness of U.S. specialty chemical manufacturing. Issues related to chemical supply chain resilience, import dependence, domestic production capacity, and availability of critical chemical inputs. Issues related to U.S. International Trade Commission examination of U.S. chemical manufacturing competitiveness and supply chains.
Issues related to Occupational Safety and Health Administration respiratory protection requirements and proposed revisions to medical evaluation requirements for employees using filtering facepiece respirators and powered air-purifying respirators.
Issues related to implementation and potential reform of the Toxic Substances Control Act (TSCA), including EPA's New Chemicals Program and review of new chemical submissions. Issues related to EPA implementation of TSCA Section 8(a)(7) PFAS reporting requirements, including reporting burden, exemptions, historical data requirements, and implementation timelines. Issues related to EPA chemical risk evaluations and risk management regulations under TSCA, including workplace protections, conditions of use, compliance requirements, and impacts on specialty chemical manufacturers. Issues related to federal policies affecting domestic specialty chemical manufacturing capacity and availability of critical chemical inputs.
Filing targets: Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Aviation Administration (FAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Security Council (NSC), Occupational Safety & Health Administration (OSHA), SENATE, Small Business Administration (SBA), State, Dept of (DOS), U.S. International Trade Commission (ITC)
SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES via SOCIETY OF CHEMICAL MANUFACTURERS & AFFILIATES
2026 · second_quarter · Q2
Issues related to tariffs, international trade, and the competitiveness of U.S. chemical manufacturing. Issues related to reshoring and domestic manufacturing policies affecting the specialty chemical industry.
Issues related to the Federal Aviation Administration's proposed rule restricting unmanned aircraft systems (UAS) operations over certain fixed-site facilities, including chemical facilities.
Issues related to the Toxic Substances Control Act and draft legislative proposals in the House and Senate. Issues related to the Environmental Protection Agencys New Chemicals Program. Issues related to the Environmental Protection Agencys Risk Management Program (RMP). Issues related to the Environmental Protection Agencys Integrated Risk Information System (IRIS). Issues related to tariffs, international trade, and the competitiveness of U.S. chemical manufacturing. Issues related to reshoring and domestic manufacturing policies affecting the specialty chemical industry. Issues related to supply chain resilience, domestic production capacity, and availability of critical chemical inputs.
Issues related to pharmaceutical supply chain resilience, domestic manufacturing of pharmaceuticals and critical chemical inputs, and reducing reliance on foreign sources.
Issues related to the Environmental Protection Agencys New Chemicals Program. Issues related to reshoring and domestic manufacturing policies affecting the specialty chemical industry.
Filing targets: Defense, Dept of (DOD), Environmental Protection Agency (EPA), Federal Aviation Administration (FAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Security Council (NSC), SENATE, Small Business Administration (SBA), State, Dept of (DOS), U.S. International Trade Commission (ITC)